Benzinga | May 17, 2021 07:38AM EDT

Paratek Pharmaceuticals Q1 EPS $(0.39) Misses $(0.38) Estimate, Sales $16.43M Miss $28.72M Estimate

Paratek Pharmaceuticals (NASDAQ:PRTK) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.38) by 2.63 percent. This is a 40.91 percent increase over losses of $(0.66) per share from the same period last year. The company reported quarterly sales of $16.43 million which missed the analyst consensus estimate of $28.72 million by 42.80 percent. This is a 107.41 percent increase over sales of $7.92 million the same period last year.